rs149419694
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BS1_SupportingBS2
The ENST00000254958.10(JAG1):c.2666G>A(p.Arg889Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000651 in 1,613,546 control chromosomes in the GnomAD database, including 1 homozygotes. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R889G) has been classified as Likely benign.
Frequency
Consequence
ENST00000254958.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JAG1 | NM_000214.3 | c.2666G>A | p.Arg889Gln | missense_variant | 22/26 | ENST00000254958.10 | NP_000205.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JAG1 | ENST00000254958.10 | c.2666G>A | p.Arg889Gln | missense_variant | 22/26 | 1 | NM_000214.3 | ENSP00000254958 | P1 | |
JAG1 | ENST00000423891.6 | n.2532G>A | non_coding_transcript_exon_variant | 20/25 | 2 | |||||
JAG1 | ENST00000617965.2 | n.3255G>A | non_coding_transcript_exon_variant | 16/17 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000636 AC: 16AN: 251426Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135884
GnomAD4 exome AF: 0.0000609 AC: 89AN: 1461350Hom.: 1 Cov.: 32 AF XY: 0.0000674 AC XY: 49AN XY: 727018
GnomAD4 genome AF: 0.000105 AC: 16AN: 152196Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74352
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 06, 2016 | The R889Q variant of uncertain significance has been published previously in association with Alagille syndrome (Warthen et al., 2006). The variant was not observed at any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. R889Q is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position where amino acids with similar properties to Arginine are tolerated across species; however, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Feb 01, 2023 | - - |
Alagille syndrome due to a JAG1 point mutation Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 04, 2023 | - - |
Uncertain significance, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | May 31, 2018 | This variant is interpreted as a Uncertain Significance - Insufficient Evidence, for Alagille syndrome 1, in Autosomal Dominant manner. The following ACMG Tag(s) were applied: BS1 => Allele frequency is greater than expected for disorder. - |
Tetralogy of Fallot;C1866053:Deafness, congenital heart defects, and posterior embryotoxon;C1956125:Alagille syndrome due to a JAG1 point mutation Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 26, 2018 | The p.R889Q variant (also known as c.2666G>A), located in coding exon 22 of the JAG1 gene, results from a G to A substitution at nucleotide position 2666. The arginine at codon 889 is replaced by glutamine, an amino acid with highly similar properties. This variant was identified in a cohort of individuals with Alagille syndrome; however, additional clinical details were not provided (Warthen DM et al. Hum. Mutat., 2006 May;27:436-43). This amino acid position is poorly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on available evidence to date, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at